Prognostic Value of ¹⁸F-Fluorocholine PET Parameters in Metastatic Castrate-Resistant Prostate Cancer Patients Treated with Docetaxel

Table 2

Whole-body semi-quantitative ¹⁸F-FCH PET parameters before (PET1) and after (PET2) treatment (median (IQR)).

	PET1	PET2
SPVC-SUV (g/cc)	21.3 (10.8–31.2)	9.1 (4.2–26.5)
SSUVmax (g/cc)	26.2 (11.2–29.9)	8.8 (3.8–22.7)
SMATV (cc)	27.1 (12.1–48.0)	14.2 (1.4–32.3)
STLA (g)	253.5 (94.7–469.8)	118.9 (12.3–251.4)